Sanofi and GSK to Unite in Vaccine Collaboration to Combat Covid-19
Sanofi and GSK are pleased to announce that they have signed a letter of intent...
We have manufactured a wide offer for multiple therapeutic areas for human and animal health.
As of today, our synthesis API portfolio counts 58 references, covering Cardiovascular diseases, Metabolic disorders, Analgesics & NSAIDs (non-fluorinated glucocorticoids and derivatives), Central nervous system disorders and Anesthetics.
Sanofi and GSK are pleased to announce that they have signed a letter of intent...
Sanofi and Regeneron Pharmaceuticals have announced the preliminary results from the Phase 2 portion of...
Sanofi Active Ingredient Solutions have more than 2,000 people developing, manufacturing and supplying active pharmaceutical...